CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Statistics

Total Valuation

CRSP has a market cap or net worth of $3.24 billion. The enterprise value is $1.56 billion.

Market Cap	3.24B
Enterprise Value	1.56B

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CRSP has 85.77 million shares outstanding. The number of shares has increased by 6.49% in one year.

Current Share Class	85.77M
Shares Outstanding	85.77M
Shares Change (YoY)	+6.49%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	73.08%
Float	85.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	85.39
Forward PS	56.81
PB Ratio	1.68
P/TBV Ratio	1.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	41.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.07, with a Debt / Equity ratio of 0.12.

Current Ratio	22.07
Quick Ratio	22.00
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -19.20% and return on invested capital (ROIC) is -13.64%.

Return on Equity (ROE)	-19.20%
Return on Assets (ROA)	-13.04%
Return on Invested Capital (ROIC)	-13.64%
Return on Capital Employed (ROCE)	-21.66%
Revenue Per Employee	$94,947
Profits Per Employee	-$931,939
Employee Count	393
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, CRSP has paid $3.59 million in taxes.

Income Tax	3.59M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.85% in the last 52 weeks. The beta is 1.84, so CRSP's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-34.85%
50-Day Moving Average	41.04
200-Day Moving Average	46.09
Relative Strength Index (RSI)	49.46
Average Volume (20 Days)	2,437,622

Short Selling Information

The latest short interest is 20.51 million, so 23.91% of the outstanding shares have been sold short.

Short Interest	20.51M
Short Previous Month	20.31M
Short % of Shares Out	23.91%
Short % of Float	24.03%
Short Ratio (days to cover)	11.75

Income Statement

In the last 12 months, CRSP had revenue of $37.31 million and -$366.25 million in losses. Loss per share was -$4.34.

Revenue	37.31M
Gross Profit	-393.59M
Operating Income	-466.57M
Pretax Income	-263.15M
Net Income	-366.25M
EBITDA	-447.31M
EBIT	-466.57M
Loss Per Share	-$4.34

Balance Sheet

The company has $1.90 billion in cash and $223.69 million in debt, giving a net cash position of $1.68 billion or $19.59 per share.

Cash & Cash Equivalents	1.90B
Total Debt	223.69M
Net Cash	1.68B
Net Cash Per Share	$19.59
Equity (Book Value)	1.93B
Book Value Per Share	22.53
Working Capital	1.85B

Cash Flow

In the last 12 months, operating cash flow was -$142.77 million and capital expenditures -$1.90 million, giving a free cash flow of -$144.68 million.

Operating Cash Flow	-142.77M
Capital Expenditures	-1.90M
Free Cash Flow	-144.68M
FCF Per Share	-$1.69

Margins

Gross Margin	n/a
Operating Margin	-1,250.38%
Pretax Margin	-971.93%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRSP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.49%
Shareholder Yield	n/a
Earnings Yield	-11.31%
FCF Yield	-4.47%

Analyst Forecast

The average price target for CRSP is $74.35, which is 96.90% higher than the current price. The consensus rating is "Buy".

Price Target	$74.35
Price Target Difference	96.90%
Analyst Consensus	Buy
Analyst Count	19
Revenue Growth Forecast (5Y)	130.16%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRSP has an Altman Z-Score of 8.7 and a Piotroski F-Score of 2.

Altman Z-Score	8.7
Piotroski F-Score	2